The global peptide therapeutics market is on a transformative trajectory, expected to surge from USD 42.1 billion in 2024 to an impressive USD 117.4 billion by 2034, registering a robust CAGR of 10.8% ...

Perspective Therapeutics, Inc.’s CATX share price has dipped by 7.63%, which has investors questioning if this is right time ...

Citizens JMP initiated coverage of MBX Biosciences (MBX) with an Outperform rating and $38 price target MBX is using its proprietary Precision ...

Vapourtec’s R-Series flow chemistry system, equipped with a UV-150 photochemical reactor, has been cited in research by scientists* at Novo Nordisk in the C-terminal a-amination of peptides and ...

Elicio Therapeutics, Inc.’s ELTX share price has surged by 5.57%, which has investors questioning if this is right time to ...

Explore JANX's promising early data in prostate cancer immunotherapy. Understand market challenges, buyout rumors, and ...

Lyophilization (freeze-drying) is commonly utilized to support peptide stability. Removing water from peptide solutions might significantly reduce hydrolysis and deamidation rates. Lyophilized ...

Perspective Therapeutics (NYSE:CATX – Free Report) had its price target cut by Royal Bank of Canada from $16.00 to $15.00 in ...

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

Perspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research ...